Age-Related Changes and Cycloplegia-Induced Differences in the Human Crystalline Lens

Sponsor
Wenzhou Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT04576884
Collaborator
(none)
129
1
10
12.9

Study Details

Study Description

Brief Summary

The ocular biometric parameters of the human crystalline lens including anterior chamber depth (ACD), lens thickness (LT), radii of curvature of anterior and posterior lens (ALR and PLR), lens equatorial diameter (LED), and lens vault (LV), automatically quantified by the CASIA2 (SS-OCT; Tomey, Nagoya, Japan). Images of iridocorneal angle were obtained using CASIA2 and the Schlemm' s canal (SC) and trabecular meshwork (TM) were quantified manually. Both cycloplegia and non-cycloplegia images were obtained.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Healthy individuals aged between 6 and 90 years, without history of ocular disease (except age-related cataract and/or myopia), were consecutively included from April to May 2019. All participants underwent visual acuity, dry and wet refraction, anterior and posterior segment examination, intraocular pressure (IOP), and axial length (AL) using IOL-Master 700 (Carl Zeiss Meditec AG). Investigators recruited children under 18 years old at a refraction outpatient clinic, who were prescribed cyclopentolate hydrochloride eyedrops (S.A. Alcon-Couvreur N.V., Belguim) for cycloplegic refraction. For adults, they were prescribed compound tropicamide eyedrops (Mydrin-P, Santen Pharmaceutical Co., Ltd, Osaka, Japan), consisting of 0.5% tropicamide mixed with 0.5% phenylephrine hydrochloride, for pupillary dilation in order to perform fundus examination at an outpatient clinic. Exclusion criteria were as follow:ocular diseases other than cataracts; history of eye surgeries or injuries; shallow anterior chamber with a risk of angle closure. The data from right eye was selected for analysis.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    129 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Age-Related Changes and Cycloplegia-Induced Differences of the Human Crystalline Lens, Schlemm' s Canal and Trabecular Meshwork:an in Vivo Swept-Source Optical Coherence Tomography Study
    Actual Study Start Date :
    Apr 1, 2019
    Actual Primary Completion Date :
    May 31, 2019
    Actual Study Completion Date :
    Jan 30, 2020

    Arms and Interventions

    Arm Intervention/Treatment
    Group 1

    participants of less than 18 years old

    Group 2

    participants aged from 18 years to 40 year

    Group 3

    participants aged from 41 years to 60 years

    Group 4

    participants over 60 years old

    Outcome Measures

    Primary Outcome Measures

    1. Paired Comparison Before and After Cycloplegia [2020.2.3]

      The cycloplegia-induced differences of parameters was defined as: the post-cycloplegic value minus the pre-cycloplegic value.

    2. Evaluated the effect of age on the TM/SC morphologies [2020.2.3]

      The age-related variations of TM/SC parameters from four age groups were compared.

    Secondary Outcome Measures

    1. Evaluated the effect of age on the ocular biometric data [2020.2.3]

      The age-related variations of ocular biometric data such as axial length (AL), lens thickness (LT), and anterior chamber depth (ACD) from four age groups were compared.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Years to 86 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Healthy individuals aged between 6 and 90 years, without history of ocular disease (except age-related cataract and/or myopia) Must be able to cooperate examination

    Exclusion Criteria:

    ocular diseases other than cataracts history of eye surgeries or injuries shallow anterior chamber with a risk of angle closure

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ophthalmology and Optometry Hospital Wenzhou Zhejiang China 325027

    Sponsors and Collaborators

    • Wenzhou Medical University

    Investigators

    • Study Director: Yune Zhao, Ophthalmology and Optometry Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yune Zhao, Vice president of Eye Hospital of Wenzhou Medical University, Wenzhou Medical University
    ClinicalTrials.gov Identifier:
    NCT04576884
    Other Study ID Numbers:
    • SSOCT-ocular parameters change
    First Posted:
    Oct 6, 2020
    Last Update Posted:
    Oct 6, 2020
    Last Verified:
    Sep 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Yune Zhao, Vice president of Eye Hospital of Wenzhou Medical University, Wenzhou Medical University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 6, 2020